Source: International Congress 2016 – Quality management and quality of life in lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Ameeka Thompson (Bath, United Kingdom), Ameeka Thompson, Andrew Low, Vidan Masani. PET-CT – Does it make a difference?. Eur Respir J 2016; 48: Suppl. 60, 3083

Member's Comments

No comment yet.

Related content which might interest you: Impact of PET scan on staging and management of lung cancer patients in Indian scenario Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 The effect of positron emission tomography (PET-CT) on the management of patients with non-small cell lung cancer (NSCLC) prior to oncological treatment Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014 Incidental findings on PET-CT scans; how they are managed and how they impact on the lung cancer pathway Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Clinical profile and survival of patients undergoing surgery for non-small cell lung cancer: Impact of positron emission tomography adoption Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014 Role of mean sUV and metabolic tumor volume by PET/CT for determination of mean survival time in patients with non-small cell lung cancer Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Preoperative FDG uptake on PET/CT predicts disease recurrence and survival in early stage non-small cell lung cancer (NSCLC) Source: International Congress 2016 – Clinical aspects of lung cancer Year: 2016 Correlation of FDG-PET/CT and EBUS-TBNA for nodal staging in lung cancer Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 Association with emphysema on computed tomography and lung cancer in smokers Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Should preoperative FDG uptake on PET/CT guide postoperative surveillance in surgical non-small cell lung cancer (NSCLC) Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Lung cancer revisited – CT scan and bronchoscopy concordance after treatment Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Should CT-guided biopsy for suspected lung cancer be delayed pending PET/CT results? Source: International Congress 2016 – Transbronchial diagnostics: from ILD to pheripheral lesions Year: 2016 Comparison between dual-energy computed tomography and standard lung perfusion scintigraphy in preoperative evaluation of lung cancer patients Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts Year: 2013 Should all lung cancer patients requiring pathological nodal staging undergo PET-CT first? Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Added value of EUS-B to EBUS for lung cancer staging Source: International Congress 2015 – Endoscopic ultrasound: an essential tool for interventional pulmonology Year: 2015 Comparing performance and cost of EBUS-TBNA versus other methods for diagnosis and staging of non-small cell lung cancer (NSCLC) Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Staging of non-small-cell lung cancer with FDG-PET/CT: Is there a correlation of morphologic tumor characteristics and metabolic activity? Source: Annual Congress 2012 - Functional imaging in pulmonary oncology and COPD. Radiation dose in chest CT: survey and real life Year: 2012 Preoperative predictive value of 18FDG CT/PET tumor metabolic parameters & SUV lymh nodes/tumor ratio in NSCLC Source: International Congress 2015 – Risk assessment and prevention of complications in thoracic surgery Year: 2015 Variation in lung cancer diagnosis in England Source: Annual Congress 2013 –Quality management in thoracic oncology Year: 2013 LATE-BREAKING ABSTRACT: Are small specimens" big enough" as therapeutic indicators in non-small cell lung cancer? Source: International Congress 2014 – New technologies and biomarkers in lung disease Year: 2014 Computed tomographic screening for lung cancer: individualising the benefit of the screening Source: Eur Respir J 2007; 30: 843-847 Year: 2007